Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Buy
52
IRIX Quote, Financials, Valuation and Earnings
Last price:
$1.70
Seasonality move
:
19.94%
Day range:
$1.62 - $1.74
52-week range:
$1.27 - $3.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.59x
P/B ratio:
11.04x
Volume:
10.6K
Avg. volume:
42.2K
1-year change:
-32.95%
Market cap:
$28.9M
Revenue:
$51.9M
EPS (TTM):
-$0.67
Analysts' Opinion
-
Consensus RatingIRIDEX has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, IRIDEX has an estimated upside of 14.94% from its current price of $1.74.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $1.74.
Fair Value
-
According to the consensus of 0 analysts, IRIDEX has 14.94% upside to fair value with a price target of -- per share.
IRIX vs. S&P 500
-
Over the past 5 trading days, IRIDEX has overperformed the S&P 500 by 0.61% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
IRIDEX does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
IRIDEX revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter IRIDEX reported revenues of $11.6M.
Earnings Growth
-
IRIDEX earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter IRIDEX reported earnings per share of -$0.12.
Enterprise value:
27.8M
EV / Invested capital:
5.17x
Price / LTM sales:
0.59x
EV / EBIT:
--
EV / Revenue:
0.57x
PEG ratio (5yr expected):
-0.07x
EV / Free cash flow:
-3.98x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$18.8M
Return On Assets:
-33.47%
Net Income Margin (TTM):
-22.79%
Return On Equity:
-157.91%
Return On Invested Capital:
-146.36%
Operating Margin:
-16.15%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $57M | $54.6M | $48.4M | $12.9M | $11.6M | |
| Gross Profit | $24.7M | $23.6M | $18.8M | $5.6M | $4.3M | |
| Operating Income | -$8.5M | -$8.3M | -$10.9M | -$1.7M | -$1.9M | |
| EBITDA | -$6.3M | -$6.8M | -$9.1M | -$1.3M | -$1.6M | |
| Diluted EPS | -$0.55 | -$0.48 | -$0.67 | -$0.11 | -$0.12 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $25.6M | $43.9M | $38.3M | $27.3M | $24.3M | |
| Total Assets | $28.5M | $50.5M | $45M | $34.9M | $30.2M | |
| Current Liabilities | $9.2M | $13M | $13.6M | $10.3M | $15.9M | |
| Total Liabilities | $11.2M | $25.2M | $26.9M | $22.9M | $27.5M | |
| Total Equity | $17.3M | $25.3M | $18.1M | $12.1M | $2.6M | |
| Total Debt | $2.5M | -- | -- | -- | $2.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$9.7M | -$7.4M | -$7M | -$1.8M | -$3.1M | |
| Cash From Investing | -$240K | -$224K | $28K | -$82K | -$1K | |
| Cash From Financing | -$34K | -$50K | $2.9M | -$24K | $2.8M | |
| Free Cash Flow | -$9.9M | -$7.6M | -$7M | -$1.9M | -$3.1M | |
IRIX
Sector
Market Cap
$28.9M
$46.1M
Price % of 52-Week High
47.67%
46.02%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
-32.95%
-30.52%
Beta (5-Year)
0.812
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$1.68
200-day SMA
Sell
Level
$2.14
Bollinger Bands (100)
Sell
Level
1.58 - 1.94
Chaikin Money Flow
Buy
Level
2.7M
20-day SMA
Sell
Level
$1.74
Relative Strength Index (RSI14)
Buy
Level
52.61
ADX Line
Buy
Level
11.62
Williams %R
Neutral
Level
-49.6697
50-day SMA
Buy
Level
$1.65
MACD (12, 26)
Sell
Level
-0.01
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
18.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-1.0619)
Sell
CA Score
(Annual)
Level (-1.8044)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (3.8546)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
Stock Forecast FAQ
In the current month, IRIX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IRIX average analyst price target in the past 3 months is --.
-
Where Will IRIDEX Stock Be In 1 Year?
According to analysts, the consensus estimate is that IRIDEX share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About IRIDEX?
Analysts are divided on their view about IRIDEX share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that IRIDEX is a Sell and believe this share price will drop from its current level to --.
-
What Is IRIDEX's Price Target?
The price target for IRIDEX over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is IRIX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for IRIDEX is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of IRIX?
You can purchase shares of IRIDEX via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase IRIDEX shares.
-
What Is The IRIDEX Share Price Today?
IRIDEX was last trading at $1.70 per share. This represents the most recent stock quote for IRIDEX. Yesterday, IRIDEX closed at $1.74 per share.
-
How To Buy IRIDEX Stock Online?
In order to purchase IRIDEX stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
